Literature DB >> 35622243

Risk factors for 1-year hospital readmissions in patients with systemic lupus erythematosus.

Jinxia Chen1, Limin Zhang2, Liutao Huang3, Shuxian Chen3, Yongzhi Xu3, Huafeng Liu4.   

Abstract

To reveal the characteristics of and risk factors for systemic lupus erythematosus (SLE) patients with frequent readmission aiming at intervening early and improve the quality of care during initial hospitalizations. This was a single-center, retrospective case-control study involving 521 hospitalized patients with SLE from January 2014 to December 2016 in the Affiliated Hospital of Guangdong Medical University. A total of 521 patients were enrolled, including 400 patients who were hospitalized once and 121 patients who were hospitalized repeatedly, and 23.2% of the patients were readmitted within 1 year. The results showed that the age of SLE onset (odds ratio [OR] 1.022, 95% confidence interval [CI] 1.007-1.036), serum albumin (OR 0.965, 95% CI 0.942-0.989), and cystatin C (OR 1.404, 95% CI 1.180-1.670) were closely related to readmission. The most common causes of readmission were infections (52 cases, 28.4%), especially respiratory tract infections, and lupus activity or recurrence (45 cases, 24.6%). Special attention should be paid to SLE patients with older age of onset, low serum albumin levels, and high cystatin C levels to avoid infection and recurrence with the aim of reducing the hospital readmission rate.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cystatin C; Infection; Lupus erythematosus; Patient readmission; Risk factors; Serum albumin; Systemic

Year:  2022        PMID: 35622243     DOI: 10.1007/s10238-022-00835-y

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  8 in total

1.  Genetic studies on systemic lupus erythematosus in East Asia point to population differences in disease susceptibility.

Authors:  Yong-Fei Wang; Yu Lung Lau; Wanling Yang
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-03-21       Impact factor: 3.908

Review 2.  Novel paradigms in systemic lupus erythematosus.

Authors:  Thomas Dörner; Richard Furie
Journal:  Lancet       Date:  2019-06-06       Impact factor: 79.321

3.  Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation.

Authors:  Jinoos Yazdany; Ben J Marafino; Mitzi L Dean; Naomi S Bardach; Reena Duseja; Michael M Ward; R Adams Dudley
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

4.  Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus.

Authors:  Mandana Nikpour; Murray B Urowitz; Dominique Ibañez; Dafna D Gladman
Journal:  Arthritis Rheum       Date:  2009-09-15

5.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.

Authors:  Candace H Feldman; Linda T Hiraki; Jun Liu; Michael A Fischer; Daniel H Solomon; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2013-03

6.  Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province.

Authors:  Yan-Feng Zou; Chen-Chen Feng; Ji-Min Zhu; Jin-Hui Tao; Gui-Mei Chen; Qian-Ling Ye; Han Cen; Rui-Xue Leng; Fa-Ming Pan; Hai-Feng Pan; Rui Li; Yin-Guang Fan; Bin Wang; Xiang-Pei Li; Feng-Yu Zhang; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-11-22       Impact factor: 2.631

Review 7.  Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.

Authors:  Ju-Yang Jung; Chang-Hee Suh
Journal:  Korean J Intern Med       Date:  2017-04-28       Impact factor: 2.884

8.  Geographical distribution, a risk factor for the incidence of lupus nephritis in China.

Authors:  Qingjun Pan; Yaning Li; Ling Ye; Zhenzhen Deng; Lu Li; Yongmin Feng; Weijing Liu; Huafeng Liu
Journal:  BMC Nephrol       Date:  2014-05-01       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.